ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
UniCredit Bank AG

UniCredit Bank AG (UV8DAE)

0.00
0.00
(0.00%)
Closed July 31 11:30AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

UV8DAE Latest News

STENTYS : hausse de 28% du chiffre d’affaires au 1er trimestre 2015

Regulatory News : STENTYS (Paris:STNT) (FR0010949404 — STNT – éligible PEA PME), société de technologie médicale qui commercialise le premier et le seul stent auto-apposant coronaire...

STENTYS : mise à disposition des documents préparatoires à l’assemblée générale mixte du 5 mai 2015

Regulatory News: STENTYS (Paris:STNT) (FR0010949404 — STNT – éligible PEA PME), société de technologie médicale qui commercialise le premier et le seul stent auto-apposant coronaire...

STENTYS : mise à disposition du rapport financier annuel 2014

Regulatory News: STENTYS (FR0010949404 — STNT – éligible PEA PME), société de technologie médicale qui commercialise le premier et le seul stent auto-apposant coronaire, informe ses...

STENTYS : Résultats annuels 2014

Chiffre d’affaires annuel en progression de +13% Trésorerie robuste de 18,6 M€ permettant le déploiement commercial de la nouvelle gamme de produits Provision sur l’étude...

STENTYS réaffirme son éligibilité au PEA-PME pour 2015/2016

Regulatory News: STENTYS (Paris:STNT) (FR0010949404 — STNT — éligible PEA-PME), société de technologie médicale qui commercialise le premier et le seul stent auto-apposant coronaire...

Stentys : Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du cod...

Situation au 28 février 2015 Regulatory News: Stentys (Paris:STNT): Nombre de titres composant le capital en circulation       11 721 371 Nombre de...

STENTYS : les résultats de la plus grande étude dans l’infarctus du myocarde publiés dans EuroIntervention

L’étude APPOSITION III a montré l’excellent niveau de sécurité de la technologie auto-apposante Regulatory News: STENTYS (Paris:STNT) (FR0010949404 — STNT — éligible PEA PME...

STENTYS annonce la publication d’une nouvelle étude sur le stent auto-apposant dans le traitement de l’artère principal...

L’étude publiée en ligne dans la revue Catheterization and Cardiovascular Interventions démontre la supériorité du stent auto-apposant à élargir le tronc commun Regulatory News :...

STENTYS étend l’usage du premier stent actif auto-apposant aux maladies artérielles des membres inférieurs

Une étude clinique démontre la capacité de STENTYS à éviter l’amputation dans 99% des cas Regulatory News : STENTYS (Paris:STNT) (FR0010949404 — STNT – éligible PEA PME), société de...

STENTYS : Bilan semestriel du contrat de liquidité conclu avec la société de bourse GILBERT DUPONT

Regulatory News : Au titre du contrat de liquidité confié par la société STENTYS (Paris:STNT) à la Société de Bourse Gilbert Dupont, à la date du 31 décembre 2014, les moyens suivants...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
IMRXImmuneering Corporation
$ 1.64
(45.13%)
4.47M
CDNACareDx Inc
$ 24.00
(20.06%)
41.86k
VEROVenus Concept Inc
$ 0.80
(14.24%)
731
CTNTCheetah Net Supply Chain Service Inc
$ 0.305
(11.44%)
5.49M
EOLSEvolus Inc
$ 13.84
(11.43%)
9.18k
ALXOALX Oncology Holdings Inc
$ 3.40
(-29.17%)
2.36M
OCGNOcugen Inc
$ 1.22
(-13.17%)
818.87k
LABStandard BioTools Inc
$ 1.95
(-12.95%)
12.59k
UDMYUdemy Inc
$ 8.19
(-11.36%)
66.87k
NRDSNerdWallet Inc
$ 13.01
(-11.07%)
7.09k
NVDANVIDIA Corporation
$ 119.07
(1.75%)
13.91M
CTNTCheetah Net Supply Chain Service Inc
$ 0.305
(11.44%)
5.49M
METAMeta Platforms Inc
$ 495.90
(4.44%)
4.87M
IMRXImmuneering Corporation
$ 1.64
(45.13%)
4.47M
SQQQProShares UltraPro Short QQQ
$ 8.49
(-1.16%)
3.89M

Discussion

View Full Feed
Nebuchadnezzar Nebuchadnezzar 3 minutes ago
whatever you say bud ;)
HIRU
blossom3 blossom3 3 minutes ago
Ackman is full of 💩💩💩💩💩
FNMA
glenn1919 glenn1919 3 minutes ago
CTNT..........................https://stockcharts.com/h-sc/ui?s=CTNT&p=W&b=5&g=0&id=p86431144783
CTNT
MasterBlastr MasterBlastr 4 minutes ago
Updated weather forecast - slight chance of rain, 5-10 mph winds pretty much through the tourney. Little chance of raw sewage spilling over onto the course. They spend $1.5 billion to clean up the Seine for the Olympics and a rain storm causes the sewage system to overflow and dump into the river.
SC8 SC8 4 minutes ago
Most likely the containment concern remains unresolved. That's most likely why they had to do more rabbits and took forever to write up the results. It's not easy to put lipstick on a pig. In any case, it's clear FDA wants a risk/benefit analysis cuz there are substantial risks to patient. Keep
RDGL
Sauerkraut Sauerkraut 4 minutes ago
But...but....but....it looks good in PR's for people who don't know.....glty
IQST
glenn1919 glenn1919 4 minutes ago
ATCH.........................https://stockcharts.com/h-sc/ui?s=ATCH&p=W&b=5&g=0&id=p86431144783
ATCH
crazy horse 0 crazy horse 0 5 minutes ago
Why does the FBI keep lying about the attempted assassination of Trump?

If Donald Trump manages to return to the White House, he had better plan on dismantling the FBI brick by brick. If he doesn’t, the bureau will bury him alive.

https://www.theblaze.com/columns/opi
arizona1 arizona1 5 minutes ago
Over years i've never seen evidence Trump used cocaine

Noel Casler talks about it and Trump has never sued him as far as I know.

[yt]N60ceYRlY2I[/yt]
Greedy G Greedy G 5 minutes ago
~META beat NVDA going to rocket some more, market up up & away imo
NVDA
DewDiligence DewDiligence 5 minutes ago
ALX -25%/AH on phase-2 data in gastric cancer:

https://www.globenewswire.com/news-release/2024/07/31/2922206/0/en/ALX-Oncology-Reports-Topline-Data-From-ASPEN-06-Phase-2-Trial-Demonstrating-Evorpacept-Improves-Tumor-Response-in-Patients-With-HER2-Positive-Gastric-Cancer.html In the f
Ricorich Ricorich 5 minutes ago
Lol you're dreaming, is impossible to find a great one like HIRU
HIRU
glenn1919 glenn1919 5 minutes ago
IMRX........................https://stockcharts.com/h-sc/ui?s=IMRX&p=W&b=5&g=0&id=p86431144783
IMRX
Harbor6460 Harbor6460 5 minutes ago
Sell if u want. It appears it doesn’t matter. Loll
CVNA
WillForeall WillForeall 5 minutes ago
Only if the perspective is of a flipping mindset. But not everyone is so talented lolzzz
HIRU
Chromosome Chromosome 5 minutes ago
RMB, that’s another way to interpret. But a 25% reduction in overall business (assuming 2/3 Medicare) means virtually all their commercial sales came from CVS which I have a hard time imagining.
But to your point, I wish one of the analysts would have clarified this once and for all.
CVS
Dubster watching Dubster watching 6 minutes ago
$9.38 target to re-enter
TSDD
Filterthenoise Filterthenoise 7 minutes ago
Framework looks set and merger shares about to be doled out upon approval
RNVA
crazy horse 0 crazy horse 0 7 minutes ago
'Disgraceful': Trump torches 'very rude' ABC News reporter at National Association of Black Journalists convention

https://www.theblaze.com/news/disgraceful-trump-torches-very-rude-abc-news-reporter-at-national-association-of-black-journalists-convention?utm_source=theblaze-breaking&
Lime Time Lime Time 7 minutes ago
It might be a good idea to accumulate and hold here. FINRA won't allow reverse split, so it's only up from these prices 🚀

Waiting for a pump 8k 🚀
ATYG
op1 op1 7 minutes ago
It would of course have to be a company that would roll up into wddd as another business which has existing revenue and profits to see dollars
Wddd is still sec compliant and if the up listing is finalized that would be tell tale along with other announcements
And maybe it would be t
WDDD

Your Recent History

Delayed Upgrade Clock